In situ covalently cross-linked PEG hydrogel for ocular drug delivery applications

International Journal of Pharmaceutics

Volumn 470, Issue 1-2, 2014, Pages 151-157

  Yu, Jing ^a   Xu, Xu ^a   Yao, Fulin ^a,b   Luo, Zichao ^a,b   Jin, Ling ^a   Xie, Binbin ^a   Shi, Shuai ^a   Ma, Huixiang ^a   Li, Xingyi ^a   Chen, Hao ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b Wenzhou Institute of Biomaterials and Engineering   (China)

Author keywords

Avastin; Corneal neovascularization; PEG hydrogel; Sustained release

Indexed keywords

BEVACIZUMAB; MACROGOL; MALEIMIDE; THIOL; HYDROGEL; MACROGOL DERIVATIVE; MALEIMIDE DERIVATIVE; MONOCLONAL ANTIBODY; THIOL DERIVATIVE;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CONCENTRATION (PARAMETERS); CORNEA NEOVASCULARIZATION; CROSS LINKING; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG HYDROLYSIS; ENCAPSULATION; HYDROGEL; HYDROLYSIS; IN VITRO STUDY; INCUBATION TIME; L929 CELL LINE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; SWELLING; ADMINISTRATION AND DOSAGE; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; FLOW KINETICS; INTRAOCULAR DRUG ADMINISTRATION;

ADMINISTRATION, OPHTHALMIC; ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; CELL LINE; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; HYDROGELS; MALEIMIDES; MICE; POLYETHYLENE GLYCOLS; RHEOLOGY; SULFHYDRYL COMPOUNDS;

EID: 84902296594     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.04.053     Document Type: Article

References (36)

1. A.K. Agrawal, M. Das, and S. Jain In situ gel systems as 'smart' carriers for sustained ocular drug delivery Expert Opinion on Drug Delivery 9 2012 383 402
2. S.S. Anumolu, A.S. DeSantis, A.R. Menjoge, R.A. Hahn, J.A. Beloni, M.K. Gordon, and P.J. Sinko Doxycycline loaded poly(ethylene glycol) hydrogels for healing vesicant-induced ocular wounds Biomaterials 31 2010 964 974
3. J.F. Arevalo, M. Maia, H.W. Flynn, M. Saravia, R.L. Avery, L. Wu, M.E. Farah, D.J. Pieramici, M.H. Berrocal, and J.G. Sanchez Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy The British Journal of Ophthalmology 92 2008 213 216 (Pubitemid 351224097)
4. R.L. Avery, J. Pearlman, D.J. Pieramici, M.D. Rabena, A.A. Castellarin, M.A. Nasir, M.J. Giust, R. Wendel, and A. Patel Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy Ophthalmology 113 2006 1695 1705 e6
5. R.L. Avery, D.J. Pieramici, M.D. Rabena, A.A. Castellarin, M.A. Nasir, and M.J. Giust Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 2006 363 372 e5
6. P. Bao, A. Kodra, M. Tomic-Canic, M.S. Golinko, H.P. Ehrlich, and H. Brem The role of vascular endothelial growth factor in wound healing Journal of Surgical Research 153 2009 347 358
7. D.R. Binder, I.P. Herring, K.L. Zimmerman, J. Phillip Pickett, and W.R. Huckle Expression of vascular endothelial growth factor receptor-1 and -2 in normal and diseased canine eyes Veterinary Ophthalmology 15 2012 223 230
8. M. Casolaro, I. Casolaro, and S. Lamponi Stimuli-responsive hydrogels for controlled pilocarpine ocular delivery European Journal of Pharmaceutics and Biopharmaceutics 80 2012 553 561
9. J.-H. Chang, K.Y. Han, and D.T. Azar Wound healing fibroblasts modulate corneal angiogenic privilege: interplay of basic fibroblast growth factor and matrix metalloproteinases in corneal angiogenesis The Japanese Journal of Ophthalmology 54 2010 199 205
10. W.-L. Chen, C.-T. Lin, N.-T. Lin, I.H. Tu, J.-W. Li, L.-P. Chow, K.-R. Liu, and F.-R. Hu Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis Investigative Ophthalmology & Visual Science 50 2009 1659 1665
11. M.H. Dastjerdi, D.R. Saban, A. Okanobo, N. Nallasamy, Z. Sadrai, S.K. Chauhan, A.R. Hajrasouliha, and R. Dana Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival Investigative Ophthalmology & Visual Science 51 2010 2411 2417
12. N.S. Elbialy, B.M. Abdol-Azim, M.W. Shafaa, L.H. El Shazly, A.H. El Shazly, and W.A. Khalil Enhancement of the ocular therapeutic effect of prednisolone acetate by liposomal entrapment Journal of Biomedical Nanotechnology 9 2013 2105 2116
13. J. Folkman, M. Klagsbrun, J. Sasse, M. Wadzinski, D. Ingber, and I. Vlodavsky A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane The American Journal of Pathology 130 1988 393
14. D. Guarnieri, A. De Capua, M. Ventre, A. Borzacchiello, C. Pedone, D. Marasco, M. Ruvo, and P.A. Netti Covalently immobilized RGD gradient on PEG hydrogel scaffold influences cell migration parameters Acta Biomaterialia 6 2010 2532 2539
15. L. Hoffart, F. Matonti, J. Conrath, L. Daniel, B. Ridings, G.S. Masson, and F. Chavane Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone Clinical Experimental Ophthalmology 38 2010 346 352
16. D. Hos, D.R. Saban, F. Bock, B. Regenfuss, J. Onderka, S. Masli, and C. Cursiefen Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids Archives of Ophthalmology 129 2011 445
17. B. Jeong, S.W. Kim, and Y.H. Bae Thermosensitive sol-gel reversible hydrogels Advanced Drug Delivery Reviews 54 2002 37 51 (Pubitemid 34075313)
18. A.M. Joussen, F.E. Kruse, H.E. Volcker, and B. Kirchhof Topical application of methotrexate for inhibition of corneal angiogenesis Graefe's Archive for Clinical and Experimental Ophthalmology 237 1999 920 927 (Pubitemid 29484167)
19. H.J. Jung, and A. Chauhan Temperature sensitive contact lenses for triggered ophthalmic drug delivery Biomaterials 33 2012 2289 2300
20. S.W. Kim, B.J. Ha, E.K. Kim, H. Tchah, and T.-I. Kim The effect of topical bevacizumab on corneal neovascularization Ophthalmology 115 2008 e33 e38
21. X. Li, Z. Zhang, J. Li, S. Sun, Y. Weng, and H. Chen Diclofenac/ biodegradable polymer micelles for ocular applications Nanoscale 4 2012 4667 4673
22. X. Li, Z. Zhang, and H. Chen Development and evaluation of fast forming nano-composite hydrogel for ocular delivery of diclofenac The International Journal of Pharmaceutics 448 2013 96 100
23. C.-C. Lin, and K.S. Anseth PEG hydrogels for the controlled release of biomolecules in regenerative medicine Pharmaceutical Research 26 2009 631 643
24. P. Liu, B. Wang, W. Qiao, and J. Li Novel thermosensitive nano-micelles from triblock copolymer for drug delivery Journal of Biomedical Nanotechnology 5 2009 310 313
25. S. Nakao, Y. Hata, M. Miura, K. Noda, Y.N. Kimura, S. Kawahara, T. Kita, T. Hisatomi, T. Nakazawa, and Y. Jin Dexamethasone inhibits interleukin-1β- induced corneal neovascularization: role of nuclear factor-κB-activated stromal cells in inflammatory angiogenesis The American Journal of Pathology 171 2007 1058 1065 (Pubitemid 47441002)
26. C.M. Nimmo, S.C. Owen, and M.S. Shoichet Diels-alder click cross-linked hyaluronic acid hydrogels for tissue engineering Biomacromolecules 12 2011 824 830
27. J.J. Perez-Santonja, E. Campos-Mollo, M. Lledo-Riquelme, J. Javaloy, and J.L. Alio Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an animal model American Journal of Ophthalmology 150 2010 519 528
28. Y. Qazi, B. Stagg, N. Singh, S. Singh, X. Zhang, L. Luo, J. Simonis, U.B. Kompella, and B.K. Ambati Nanoparticle-mediated delivery of shRNA. VEGF-A plasmids regresses corneal neovascularization Investigative Ophthalmology & Visual Science 53 2012 2837 2844
29. Y. Qiu, and K. Park Environment-sensitive hydrogels for drug delivery Advanced Drug Delivery Reviews 64 2012 49 60
30. K.M. Schultz, A.D. Baldwin, K.L. Kiick, and E.M. Furst Gelation of covalently cross-linked PEG-heparin hydrogels Macromolecules 42 2009 5310 5316
31. B. Stella, S. Arpicco, F. Rocco, S. Burgalassi, N. Nicosia, S. Tampucci, P. Chetoni, and L. Cattel Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits European Journal of Pharmaceutics and Biopharmaceutics 80 2012 39 45
32. S. Swaminathan, P.R. Vavia, F. Trotta, and R. Cavalli Nanosponges encapsulating dexamethasone for ocular delivery: formulation design, physicochemical characterization, safety and corneal permeability assessment Journal of Biomedical Nanotechnology 9 2013 998 1007
33. H. Tan, A.J. DeFail, J.P. Rubin, C.R. Chu, and K.G. Marra Novel multiarm PEG-based hydrogels for tissue engineering Journal of Biomedical Materials Research Part A 92 2010 979 987
34. S. Van Vlierberghe, P. Dubruel, and E. Schacht Biopolymer-based hydrogels as scaffolds for tissue engineering applications: a review Biomacromolecules 12 2011 1387 1408
35. N.A. Whitlock, B. McKnight, K.N. Corcoran, L.A. Rodriguez, and D.S. Rice Increased intraocular pressure in mice treated with dexamethasone Investigative Ophthalmology & Visual Science 51 2010 6496 6503
36. I.-C. You, I.-S. Kang, S.-H. Lee, and K.-C. Yoon Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization Acta Ophthalmologicacta 87 2009 653 658